City

Ghent (1)

London (1)

Condition

Prognostic Biomarkers (3)

Circulating Endothelial Cells (1)

Circulating Tumor Cells (1)

Clear Cell Renal Cancer (1)

Liver Transplant Failure (1)

Pancreatic Cancer (1)

Predictive Biomarkers (1)

Proteomics (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

Sponsor

Lawson Health Research Institute (1)

The Affiliated Hospital of Qingdao University (1)

University Hospital, Ghent (1)

Collaborator

Cliniques universitaires Saint-Luc- Universite Catholique de Louvain (1)

Fund for Scientific Research, Flanders, Belgium (1)

Hamilton Health Sciences Corporation (1)

London Health Sciences Centre (1)

Universitaire Ziekenhuizen KU Leuven (1)

University Hospital, Antwerp (1)

Intervention

glycotransplanttest (1)

no intervention (1)

none- observational study (1)

Study Documents

Intervention Type

other (2)

diagnostic test (1)

Funder Type

Other (3)

Study Type

Observational (3)

prognostic biomarkers

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Serum GLYcomics to Predict Graft Loss and Mortality After Liver

Recruiting

Liver Transplant Failure
Prognostic Biomarkers

GlycoTransplantTest

Ghent, Flanders, Belgium

Xavier Verhelst

May 10, 2023

Pancreatic Cancer Based on Proteomic Techniques

Not yet recruiting

Proteomics
+2 more

No intervention

(no location specified)

Mar 17, 2022

Circulating Tumor Cells & Circulating Endothelial Cells as

Completed

Clear Cell Renal Cancer
+4 more

None- observational study

London, Ontario, Canada

London Health Sciences Centre

Dec 20, 2019